CAR-T Referral Process: Insights from Emory : Episode 4
CAR-T Therapy: Approach to Bridging
Panelists explain how CAR-T cell therapy works and describe the treatment process, discussing whether CAR -T is considered a complex procedure at their institution or if the logistics have been streamlined into clinical workflows, and they also detail their institution's approach to bridging therapy for patients awaiting CAR-T manufacturing and infusion, including whether patients are managed in-house or sent back to community centers.
Video content above is prompted by the following:
- Could you explain how CAR-T cell therapy works and describe the treatment process?
- Do you consider CAR-T therapy a complex process at your institution, or have you been able to streamline the logistics and integration into clinical workflows?
- Can you explain your institution's approach to bridging therapy for patients awaiting CAR-T manufacturing and infusion?
- Do you send patients back to community centers or is does it the treatment happen done in-house?
Recent Videos
Related Content
